EGCG has been reported to disrupt the MDM2 and p53 interaction in human lung cancer cells, which resulted in the inhibition of MDM2-mediated p53 ubiquitylation and subsequent degradation31. This evidence concerns the gene MDM2 and lung carcinoma.